Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.

Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.

The purpose of this study was to evaluate the contribution of DT-diaphorase inhibition to in vivo neurodegenerative effects of dopamine (DA) oxidation to the corresponding o-quinones. The neurotoxicity to nigrostriatal DA neurons was induced by injection of manganese pyrophosphate (Mn(3+)) complex a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Díaz-Véliz, G, Mora, S, Gómez, P, Dossi, M, Montiel, J, Arriagada, C, Aboitiz, F, Segura-Aguilar, J
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

Behavioral effects of aminochrome and dopachrome injected in the rat substantia nigra.
per: Díaz-Véliz, G, et al.
Publicat: (2002)

Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase
per: Juan Segura-Aguilar, et al.
Publicat: (2022-01-01)

Stereotaxic Injection of LPS into Mouse Substantia Nigra
per: Huiming Gao
Publicat: (2012-04-01)

Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor.
per: Fumihiko Takeuchi, et al.
Publicat: (2019-01-01)

Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
per: Kelley, A, et al.
Publicat: (1978)

Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo.
per: Hulley, P, et al.
Publicat: (1995)

Proteome analysis of human substantia nigra in Parkinson's disease
per: Werner Cornelius J, et al.
Publicat: (2008-02-01)

Spontaneous and amphetamine-induced behavior after bilateral injection of ethanolamine-O-sulfate into the substantia nigra.
per: Koob, G, et al.
Publicat: (1978)

Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1)
per: Monika Kadela-Tomanek, et al.
Publicat: (2022-09-01)

Substantia nigra alterations in mice modeling Parkinson’s disease
per: I. N. Rozhkova, et al.
Publicat: (2024-11-01)

Ninetieth Anniversary of Parkinson’s Disease «Substantia Nigra» Theory
per: O.N. Voskresenskaya, et al.
Publicat: (2009-06-01)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
per: T. N. Seyfried, et al.
Publicat: (2018-06-01)

Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide
per: Yazmin M. Flores-Martinez, et al.
Publicat: (2018-01-01)

ISOLATION AND CHARACTERIZATION OF SINGLE NEURONS FROM GUINEA-PIG SUBSTANTIA-NIGRA
per: Hainsworth, A, et al.
Publicat: (1990)

Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
per: Paola Feraco, et al.
Publicat: (2021-06-01)

Classification of Parkinson’s Disease in Patch-Based MRI of Substantia Nigra
per: Sayyed Shahid Hussain, et al.
Publicat: (2023-08-01)

Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease
per: Lei Liu, et al.
Publicat: (2023-09-01)

Anatomical and functional organization of the human substantia nigra and its connections
per: Yu Zhang, et al.
Publicat: (2017-08-01)

The effect of titanium dioxide nanoparticles on mice midbrain substantia nigra
per: Zahra Heidari, et al.
Publicat: (2019-07-01)

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
per: Conant Stephanie B, et al.
Publicat: (2006-10-01)

Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity
per: Juan F. Vázquez-Costa, et al.
Publicat: (2017-08-01)

Action of Dicumarol on Glucosamine-1-Phosphate Acetyltransferase of GlmU and Mycobacterium tuberculosis
per: Xiuyan Han, et al.
Publicat: (2019-08-01)

Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease
per: Dhairya A. Lakhani, et al.
Publicat: (2024-01-01)

Moderate Changes in CO2 Modulate the Firing of Neurons in the VTA and Substantia Nigra
per: Emily Hill, et al.
Publicat: (2020-07-01)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
per: Helena Xicoy, et al.
Publicat: (2020-08-01)

Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease
per: Stefania Romeo, et al.
Publicat: (2014-01-01)

Stereotaxic Infusion of LPS into Rat Substantia Nigra via Osmotic Minipump
per: Huiming Gao
Publicat: (2012-04-01)

Local iron deficiency in the substantia nigra directly contributes to hyperlocomotion phenotypes
per: Zhuo Wang, et al.
Publicat: (2022-06-01)

Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
per: Dmitrii E. Korzhevskii, et al.
Publicat: (2021-09-01)

Blood-Derived α-Synuclein Aggregated in the Substantia Nigra of Parabiotic Mice
per: Xizhen Ma, et al.
Publicat: (2021-08-01)

Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry
per: Malte Brammerloh, et al.
Publicat: (2021-10-01)

Verbascoside promotes the regeneration of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra
per: Jian-qing Liang, et al.
Publicat: (2016-01-01)

Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons
per: Daniel J Galtieri, et al.
Publicat: (2017-10-01)

Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.
per: Garcia-Reitboeck, P, et al.
Publicat: (2013)

Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
per: Wenjia Zhang, et al.
Publicat: (2017-01-01)

α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
per: Maya G. Purisai, et al.
Publicat: (2005-12-01)

Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra.
per: Alison L McCormack, et al.
Publicat: (2010-01-01)

Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
per: Florian Ermini, et al.
Publicat: (2024-04-01)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
per: Katrina Albert, et al.
Publicat: (2019-06-01)

TOLBUTAMIDE REVERSES HYPOGLYCEMIA-INDUCED HYPERPOLARIZATION IN GUINEA-PIG ISOLATED SUBSTANTIA-NIGRA NEURONS
per: Roeper, J, et al.
Publicat: (1990)